1. Drug‐resistance development differs between HIV‐1‐infected patients failing first‐line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues1. Issue 9 (13th May 2013) Authors: Santoro, MM; Sabin, C; Forbici, F; Bansi, L; Dunn, D; Fearnhill, E; Boumis, E; Nicastri, E; Antinori, A; Palamara, G; Callegaro, A; Francisci, D; Zoncada, A; Maggiolo, F; Zazzi, M; Perno, CF; Ceccherini‐Silberstein, F; Mussini, C Journal: HIV medicine Issue: Volume 14:Issue 9(2013:Oct.) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗